Table 3.
Multivariate analysis of association between blood pressure levels and mortality at follow‐up
1‐month follow‐up | 3‐month follow‐up | 12‐month follow‐up | |||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | p | HR | 95% CI | p | HR | 95% CI | p | |
BP at ER | |||||||||
SBP | 1 | 0.98–1.012 | .965 | 1 | 0.99–1.009 | .923 | 0.994 | 0.986–1.002 | .154 |
MAP | 1.007 | 0.988–1.098 | .465 | 1.003 | 0.987–1.020 | .725 | 0.993 | 0.980–1.006 | .295 |
BP change | |||||||||
ΔSBP | 0.981 | 0.968–0.994 | .005 | 0.989 | 0.981–0.998 | .014 | 0.989 | 0.982–0.996 | .003 |
ΔMAP | 0.961 | 0.940–0.983 | <.001 | 0.97 | 0.953–0.987 | .001 | 0.982 | 0.97–0.993 | .002 |
BP, blood pressure; ER, emergency room; HR, hazard ratio; SBP, systolic blood pressure; MAP, mean arterial pressure.
Age, sex, NIHSS score in the acute setting, congestive heart failure, diabetes mellitus (type 1 and type 2), and history of ischemic stroke (IS)were used as covariates. In the analyses of ΔSBP and ΔMAP, SBP and MAP, respectively, were also included as covariates.